Gene · 8115
Papers1,926
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 1,926
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| B-1 derived anti-Thy-1 B cells in old aged mice develop lymphoma/leukemia with high expression of CD11b and Hamp2 that different from TCL1 transgenic mice. | Immun Ageing | 2024 | 38570827 | PubTator, text mining | PubMed |
| An unappreciated cell survival-independent role for BAFF initiating chronic lymphocytic leukemia. | Front Immunol | 2024 | 38469292 | PubTator, text mining | PubMed |
| [Durable remission of T-cell prolymphocytic leukemia with CLEC16A::IL2 after allogeneic hematopoietic stem cell transplantation]. | Rinsho Ketsueki | 2024 | 38311387 | PubTator, text mining | PubMed |
| Mechanism of pachymic acid in the treatment of gastric cancer based on network pharmacology and experimental verification. | World J Gastrointest Oncol | 2024 | 38292852 | PubTator, text mining | PubMed |
| A neutrophil extracellular trap-related risk score predicts prognosis and characterizes the tumor microenvironment in multiple myeloma. | Sci Rep | 2024 | 38278930 | PubTator, text mining | PubMed |
| Rapamycin as a Potential Alternative Drug for Squamous Cell Gingiva Carcinoma (Ca9-22): A Focus on Cell Cycle, Apoptosis and Autophagy Genetic Profile. | Pharmaceuticals (Basel) | 2024 | 38276004 | PubTator, text mining | PubMed |
| MicroRNAs as Potential Graft Rejection or Tolerance Biomarkers and Their Dilemma in Clinical Routines Behaving like Devilish, Angelic, or Frightening Elements. | Biomedicines | 2024 | 38255221 | PubTator, text mining | PubMed |
| Incorporation of emergent symptoms and genetic covariates improves prediction of aromatase inhibitor therapy discontinuation. | JAMIA Open | 2024 | 38250582 | PubTator, text mining | PubMed |
| Driver mutation zygosity is a critical factor in predicting clonal hematopoiesis transformation risk. | Blood Cancer J | 2024 | 38225345 | PubTator, text mining | PubMed |
| Diagnostic management of blastic plasmacytoid dendritic cell neoplasm (BPDCN) in close interaction with therapeutic considerations. | Ann Hematol | 2024 | 38194088 | PubTator, text mining | PubMed |
| Developmental basis of SHH medulloblastoma heterogeneity. | Nat Commun | 2024 | 38191555 | PubTator, text mining | PubMed |
| Compartments in medulloblastoma with extensive nodularity are connected through differentiation along the granular precursor lineage. | Nat Commun | 2024 | 38191550 | PubTator, text mining | PubMed |
| Isolated Myeloid Sarcoma Masquerading as Scattered Abscesses in a Septic Patient: A Case Report and Literature Review. | Case Rep Oncol | 2024 | 38188484 | PubTator, text mining | PubMed |
| Acute myeloid leukemia cutis with KMT2A::MLLT3 fusion presenting with leonine facies. | Leuk Res Rep | 2024 | 38162585 | PubTator, text mining | PubMed |
| Multiple regulatory roles of the transfer RNA-derived small RNAs in cancers. | Genes Dis | 2024 | 37692525 | PubTator, text mining | PubMed |
| Tagraxofusp for blastic plasmacytoid dendritic cell neoplasm. | Haematologica | 2024 | 36951152 | PubTator, text mining | PubMed |
| Metabolic control of induced pluripotency. | Front Cell Dev Biol | 2023 | 38274274 | PubTator, text mining | PubMed |
| Metabolomics-transcriptomics joint analysis: unveiling the dysregulated cell death network and developing a diagnostic model for high-grade neuroblastoma. | Front Immunol | 2023 | 38239355 | PubTator, text mining | PubMed |
| Editorial for the IJMS Special Issue on Molecular Pathogenesis and Molecular Therapy of Lymphoid Malignancies. | Int J Mol Sci | 2023 | 38203728 | PubTator, text mining | PubMed |
| Multiple Genomic Alterations, Including a Novel AFF4::IRF1 Fusion Gene, in a Treatment-Refractory Blastic Plasmacytoid Dendritic-Cell Neoplasm: A Case Report and Literature Review. | Int J Mol Sci | 2023 | 38203475 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8115/papers?page=7